MicroRNAs in childhood nephrotic syndrome. Issue 10 (5th April 2021)

• Record Type: Journal Article
• Authors: Dhandapani, Mohanapriya C.; Venkatesan, Vettriselvi; Pricilla, Charmine
• Is Part Of: Journal of cellular physiology. Volume 236:Issue 10(2021)
• Page Start: 7186
• Page End: 7210
• Publication Date: 2021-04-05
• Subjects: microRNAs -- molecular -- nephrotic syndrome -- noninvasive -- pathogenesis -- urinary; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.30374
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: The discovery of microRNAs (miRNAs) has opened up new avenues of research to understand the molecular basis of a number of diseases. Because of their conservative feature in evolution and important role in the physiological function, microRNAs could be treated as predictors for disease classification and clinical process based on the specific expression. The identification of novel miRNAs and their target genes can be considered as potential targets for novel drugs. Furthermore, currently, the circulatory and urinary exosomal miRNAs are gaining increasing attention as their expression profiles are often associated with specific diseases, and they exhibit great potential as noninvasive or minimally invasive biomarkers for the diagnosis of various diseases. The remarkable stability of these extracellular miRNAs circulating in the blood or excreted in the urine underscored their key importance as biomarkers of certain diseases. There is voluminous literature concerning the role of microRNAs in other diseases, such as cardiovascular diseases, diabetic nephropathy, and so forth. However, little is known about their diagnostic ability for the pediatric nephrotic syndrome (NS). The present review article highlights the recent advances in the role of miRNAs in the pathogenesis and molecular basis of NS with an aim to bring new insights into further research applications for the development of new therapeutic agents for NS.